Anemia management protocols: providing consistent hemoglobin outcomes
- PMID: 16180783
Anemia management protocols: providing consistent hemoglobin outcomes
Abstract
Anemia management protocols encourage a consistent therapeutic approach that can increase the likelihood of patients achieving and maintaining stable hemoglobin levels within the target range of 17 to 12 g/dL recommended by the National Kidney Foundation. This article provides an overview of current concepts of anemia management that can be integrated into protocol development and refinement.
Similar articles
-
Anemia management protocols and epoetin alfa administration: an algorithm approach. Case study of the anemic patient.Nephrol Nurs J. 2002 Jun;29(3):297-300. Nephrol Nurs J. 2002. PMID: 12164081
-
Assessing hyporesponse to Epoetin alfa: an algorithm approach: case study of the anemic patient.Nephrol Nurs J. 2000 Oct;27(5):517-20. Nephrol Nurs J. 2000. PMID: 16649327
-
Supporting epoetin alfa stimulated erythropoiesis: identifying appropriate iron levels: case study of the anemic patient.Nephrol Nurs J. 2000 Dec;27(6):612-5. Nephrol Nurs J. 2000. PMID: 16649342 Review.
-
Epoetin alfa use in patients with ESRD: an analysis of recent US prescribing patterns and hemoglobin outcomes.Am J Kidney Dis. 2005 Sep;46(3):481-8. doi: 10.1053/j.ajkd.2005.05.018. Am J Kidney Dis. 2005. PMID: 16129210
-
Updating practices in an evolving IV iron and anemia environment: practical solutions.Nephrol Nurs J. 2007 Sep-Oct;34(5):533-41; quiz 542-3. Nephrol Nurs J. 2007. PMID: 18041456 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical